A single‐day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies. - Li, Eric Wenlong; Jones, Esther; Bryant, Christian; King, Tracy; Talaulikar, Dipti; Ng, Jun Yen; Bryant, Adam; Ridha, Zainab; Doo, Nicole Wong; Menzies, Anna; Ling, Silvia; Ho, Shir Jing; et al. (European Journal of Haematology, 2024)